Status:
ACTIVE_NOT_RECRUITING
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Squamous Cell Carcinoma
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
This study examines tumor- en surgical characteristics of stage T3 cutaneous squamous cell carcinomas on the scalp, diagnosed between 2010 and 2018. Histological data and patient- and tumor characteri...
Detailed Description
Cutaneous squamous cell carcinoma is the second most common type of non-melanoma skin cancer, following basal cell carcinoma. Following the American Joint Committee on Cancer Tumour, Node and Metastas...
Eligibility Criteria
Inclusion
- stage T3 cutaneous squamous cell carcinoma of the scalp (histologically proven)
- surgical treatment or radiotherapy treatment
Exclusion
- metastasis by diagnosis
- stage T1/T2/T4
Key Trial Info
Start Date :
May 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT05987579
Start Date
May 3 2021
End Date
December 1 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ellen Oyen
Maastricht, Netherlands